Nyra Health secures major funding to tackle stroke and dementia
German healthtech startup nyra health has raised €20 million to accelerate the development and rollout of its digital neurotherapy platform, aiming to address the country’s mounting burden from stroke and dementia, which is estimated to cost Germany around €65 billion each year.
The fresh capital will be used to scale clinical deployment, deepen product research and expand partnerships with hospitals, rehabilitation clinics and insurers. The company’s platform combines clinically validated cognitive training with data-driven monitoring, designed to support patients recovering from neurological events and those living with degenerative brain conditions.
Digital neurotherapy for a system under strain
Nyra health offers app-based digital neurotherapy programs that target memory, attention, language and executive function. Using adaptive AI algorithms, the software personalises exercises to each patient’s performance, providing real-time feedback to clinicians and therapists.
Germany faces a rapidly ageing population and rising incidence of neurological disorders. Traditional rehabilitation is resource-intensive, often limited by staff shortages and geographic access. By delivering therapy remotely and continuously, nyra health’s platform aims to extend care beyond the clinic and support earlier intervention, which research shows can significantly improve outcomes and reduce long-term care costs.
Clinical validation and expansion plans
The startup is working with leading German university hospitals and rehabilitation centres to integrate its tools into standard care pathways. Early studies have indicated improvements in patients’ cognitive performance and adherence compared with conventional paper-based training.
With this €20 million round, nyra health plans to strengthen its evidence base through larger clinical trials, pursue digital therapeutics reimbursement pathways and explore expansion into other European healthcare systems facing similar cost pressures from stroke and dementia.
As payers increasingly look for measurable, technology-enabled solutions, nyra health’s model aligns with a broader shift toward outcome-based, data-informed healthcare. If successful at scale, its platform could help relieve a portion of Germany’s €65 billion annual economic burden while improving quality of life for patients and caregivers.